Search Results

The product title you are looking for is no longer available. Other similar products that may interest you are listed below:

Refine your Search

Results for 'Sanofi-Aventis'
Title Publication Date Price Relevance
Sanofi-Aventis: PharmaVitae Model Jan 2009 £3,605 100%
Sanofi-aventis-Detailed Product Pipeline Mar 2011 £475 99%
Sanofi-Aventis Generics Company Intelligence Report Jan 2012 £195 99%
Sanofi-Aventis
PharmaVitae Profile
 Nov 2010 £3,605 99%
sanofi-aventis: Corporate Analysis May 2008 £255 99%
Sanofi-aventis-Therapeutic Competitors Report Mar 2011 £220 99%
sanofi-aventis K.K.-Therapeutic Competitors Report Mar 2011 £220 99%
Sanofi-Aventis Germany GmbH-Therapeutic Competitors Report Mar 2011 £220 98%
Sanofi-Aventis - Product Pipeline Review
Q4 2010
 Nov 2010 £315 98%
Sanofi-aventis: Pipeline, Products, Performance, Potential Sep 2007 £595 98%
Sanofi - Aventis seals Licensing Deal with Glenmark for $613m
Deal Analysis from GlobalData
 May 2011 £315 98%
Sanofi-Aventis - Pharmaceuticals & Healthcare
Deals and Alliances Profile
 Jul 2009 £160 98%
Deal Making Spotlight on Sanofi-Aventis
Spotlight Report Series
 Apr 2006 £630 98%
Sanofi-aventis-Deals & Alliances Report Mar 2011 £380 98%
Sanofi-Aventis
Market Share Analysis
 Oct 2010 £630 98%
Partnering Agreements with Sanofi-Aventis 2010 Jan 2010 £630 97%
Sanofi Market Share Analysis Dec 2011 £630 93%
Global Pharmaceuticals Jan 2011 £160 90%
Global Vaccines Market 2010-2025 Mar 2010 £1,499 90%
Pharmaceuticals in Russia Jan 2011 £160 90%
Pharmaceuticals in Europe Jan 2011 £160 89%
Pharmaceuticals in Australia Jan 2011 £160 89%
Biotechnology in Belgium Sep 2011 £160 89%
Pharmaceuticals in Japan Jan 2011 £160 89%
Pharmaceuticals in New Zealand Jan 2011 £160 89%
Generics in Spain Sep 2011 £160 89%
Generics in Belgium Sep 2011 £160 89%
OTC Pharmaceuticals in Brazil Nov 2010 £160 89%
OTC Pharmaceuticals in Spain Nov 2010 £160 88%
OTC Pharmaceuticals in France Nov 2010 £160 88%